Position in ZTS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,599
-$2,020 QoQ
Shares Held
64
+14.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,294
of 1,408 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Signature Equity Partners, LLC holds $362,369 across 17 Drug Manufacturers - Specialty & Generic names. ZTS ranks #10 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
4,140 | $101,885 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,068 | $70,417 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
118 | $63,935 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
1,566 | $54,293 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
4,918 | $22,081 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
458 | $15,517 | |
| 7 | HLN |
Haleon plc
|
1,416 | $13,211 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
401 | $6,428 |
All Filings in ZTS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,599 | 64 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $6,619 | 56 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $103,675 | 824 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||